Search Within

Michael Andrew Postow

  1. "Medical Physics"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (4)
  2. GSK Faculty (4)
  3. Medical Physics (4)
  4. Melanoma Disease Management Team (4)
  5. Melanoma and Immunotherapeutics Service (4)
  6. Radiology, Department of (4)

More Groups

People
  1. Jason Lewis (3)
  2. Jedd Wolchok (3)
  3. James Harding (2)
  4. Joseph O'Donoghue (2)
  5. Martha Ziolkowska (2)
  6. Matthew Hellmann (2)

More People

Years
  1. 2025 (1)
  2. 2020 (1)
  3. 2018 (1)
  4. 2017 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (2)
  2. Journal of Nuclear Medicine (2)
Publishers
  1. Biomed Central Ltd (2)
  2. Society of Nuclear Medicine (2)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • IL13Rα2-targeting antibodies for immuno-PET in solid malignancies
    Journal Article

    Gajecki, L.; Lebedeva, I. V.; Liao, Y. R.; Ambriz, D.; Carter, L. M.; Kumpf, M.; Lovibond, S.; Hachey, J. S.; Graham, M. S.; Postow, M.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • First-in-humans imaging with (89)Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: Preliminary pharmacokinetics, biodistribution, and lesion targeting
    Journal Article

    Pandit-Taskar, N.; Postow, M. A.; Hellmann, M. D.; Harding, J. J.; Barker, C. A.; O'Donoghue, J. A.; Ziolkowska, M.; Ruan, S.; Lyashchenko, S. K.; Tsai, F.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Imaging of tumor infiltrating T cells with an anti-CD8 minibody 89Zr-IAB22M2C in advanced solid tumors: A phase I first-in-human study
    Meeting Abstract

    Gordon, M. S.; Tsai, F.; Postow, M.; Hellmann, M.; Harding, J. J.; Korn, R. L.; Farwell, M. D.; Mitchell, T. C.; Schuchter, L. M.; Ziolkowska, M.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; Efficacy and safety of combined treatment
    Journal Article

    Anderson, E. S.; Postow, M. A.; Wolchok, J. D.; Young, R. J.; Ballangrud, A.; Chan, T. A.; Yamada, Y.; Beal, K.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save